<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue -//ES//DTD journal article DTD version 5.5.0//EN//XML?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName art550.dtd?><?SourceDTD.Version 5.5.0?><?ConverterInfo.XSLTName elsevier2nlmx2.xsl?><?ConverterInfo.Version 1?><?origin publisher?><?FILEmeta_TOXREP686 xml ?><?FILEmain xml ?><?FILEmain pdf ?><?FILEgr1 jpg ?><?FILEgr2 jpg ?><?FILEgr3 jpg ?><?FILEmmc1 zip ?><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Toxicol Rep</journal-id><journal-id journal-id-type="iso-abbrev">Toxicol Rep</journal-id><journal-title-group><journal-title>Toxicology Reports</journal-title></journal-title-group><issn pub-type="epub">2214-7500</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6444129</article-id><article-id pub-id-type="publisher-id">S2214-7500(18)30517-1</article-id><article-id pub-id-type="doi">10.1016/j.toxrep.2019.03.006</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Reducing oxidative toxicity of L-dopa in combination with two different antioxidants: an essential oil isolated from Rosa Damascena Mill., and vitamin C</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Nikolova</surname><given-names>Galina</given-names></name><email>gnikolova@gmail.com</email><email>gnikolova@mail.bg</email><xref rid="cor0005" ref-type="corresp">&#x0204e;</xref></contrib><contrib contrib-type="author"><name><surname>Karamalakova</surname><given-names>Yanka</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gadjeva</surname><given-names>Veselina</given-names></name></contrib></contrib-group><aff id="aff0005">Department of chemistry and biochemistry, Medical Faculty, Trakia University, 11 Armeiska Str., 6000 Stara Zagora, Bulgaria</aff><author-notes><corresp id="cor0005"><label>&#x0204e;</label>Correspondent author at: Dept. Chemistry and Biochemistry, Medical Faculty, Trakia University, 11 Armeiska Str., 6000 Stara Zagora, Bulgaria. <email>gnikolova@gmail.com</email><email>gnikolova@mail.bg</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>22</day><month>3</month><year>2019</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>22</day><month>3</month><year>2019</year></pub-date><volume>6</volume><fpage>267</fpage><lpage>271</lpage><history><date date-type="received"><day>20</day><month>7</month><year>2018</year></date><date date-type="rev-recd"><day>14</day><month>3</month><year>2019</year></date><date date-type="accepted"><day>21</day><month>3</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; 2019 Published by Elsevier B.V.</copyright-statement><copyright-year>2019</copyright-year><copyright-holder/><license license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/"><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p></license></permissions><abstract abstract-type="author-highlights" id="abs0005"><title>Highlights</title><p><list list-type="simple" id="lis0005"><list-item id="lsti0005"><label>&#x02022;</label><p id="par0005">To avoid L-dopa side effects it&#x02019;s administration is delayed.</p></list-item><list-item id="lsti0010"><label>&#x02022;</label><p id="par0010">Natural antioxidants have wide range of medicinal properties.</p></list-item><list-item id="lsti0015"><label>&#x02022;</label><p id="par0015">The natural antioxidants might inhibit oxidation and toxin formation.</p></list-item><list-item id="lsti0020"><label>&#x02022;</label><p id="par0020">The L-dopa use with antioxidants, may be a necessary approach in modern PD therapy.</p></list-item></list></p></abstract><abstract id="abs0010"><p>Parkinson disease (PD) is a multifactorial disease that takes a leading place among contemporary frequent diseases of the central nervous system (CNS) with not well-established mechanism. One of the most popular and effective therapy for patients with PD is Levodopa (L-dopa), but clinical effect of the drug diminished by motor complications resulting from prolonged treatment. Due to the L-dopa neurotoxic effect in the disease treatment, the L-dopa administration is delayed as long as possible in order to avoid side effects. In addition, combining L-dopa therapy with antioxidants, may decrease side-effects and provide symptomatic relief. The aim of the current research was to explore the possibility to reduce the oxidative stress (OS) induced by the L-dopa after its combining with two different antioxidants an essential oil isolated from Rosa damascena Mill., and vitamin C through experimental model of healthy mice. For this purpose, some oxidative stress indicators were evaluated - the lipid and protein oxidation end products &#x02013; such as lipid peroxidation products measured as malondialdehyde (MDA) levels, protein carbonyl content (PCC), and advanced glycation end products (AGEs) in blood plasma of the experimental mice. For this purpose, was studied blood isolated from healthy mice after i.p. treatment with L-dopa (100&#x02009;mg/kg). The groups with combining therapy were pre-treated first with Ascorbic acid (400&#x02009;mg/kg), Rose oil (400&#x02009;mg/kg). Statistically significant increased MDA levels, PCC and AGEs were found in the blood L-dopa treated mice compared to the controls, while the same parameters were significantly decreased in group pre-treated with antioxidants compared to the same controls. As a conclusion, the studied antioxidants can protect organisms from induced L-dopa oxidative toxicity and may play a key role in end products protection.</p></abstract><kwd-group id="kwd0005"><title>Keywords</title><kwd>Parkinson disease</kwd><kwd>Oxidative stress</kwd><kwd>L-dopa</kwd><kwd>Antioxidants</kwd><kwd>PCC</kwd><kwd>AGEs</kwd></kwd-group></article-meta></front><body><sec id="sec0005"><label>1</label><title>Introduction</title><p id="par0025">Parkinson disease (PD) is a multifactorial disease that takes a leading place among contemporary frequent diseases of the central nervous system (CNS) with not well-established mechanism [<xref rid="bib0005" ref-type="bibr">1</xref>]. The major clinical disturbances in PD are dopamine depletion consequence in the neostriatum, due to dopaminergic neurons&#x02019; degeneration [<xref rid="bib0010" ref-type="bibr">2</xref>]. The drug therapy depends on disease severity, remains relatively nonspecific and limited long term efficacy. In the early disease stages, is used a monoamine oxidase &#x003b2;-inhibitor. Initially, the drug is used to inhibit the dopamine degradation [<xref rid="bib0015" ref-type="bibr">3</xref>]. In later disease phases, the patients are treated with Levodopa (L-dopa) a dopamine precursor [<xref rid="bib0020" ref-type="bibr">4</xref>]. The dihydroxyphenylalanine (Levodopa, L-dopa) - is a "gold standard" and the most effective symptomatic treatment for PD, against which new drugs are compared [<xref rid="bib0025" ref-type="bibr">5</xref>]. A number of therapies have been developed in an attempt to improve the disease treatment, such as dopaminergic agonists and inhibitors COMT and MAO-B, but most patients still depend on L-dopa because it is the most able to control the PD symptoms [<xref rid="bib0030" ref-type="bibr">6</xref>]. The L-dopa clinical effect is diminished by motor complications resulting from prolonged treatment. Due to the L-dopa neurotoxic effect in the disease treatment, the L-dopa administration is delayed as long as possible in order to avoid side effects [<xref rid="bib0035" ref-type="bibr">7</xref>].</p><p id="par0030">Over the last decade, many different hypothesis, including oxidant-antioxidant theory, have been suggested to explain the etiology of PD. Local and systemic oxidative injuries, triggered by free radicals and reactive oxygen species (ROS), may be a reason for dopaminergic neurons&#x02019; degeneration [<xref rid="bib0040" ref-type="bibr">8</xref>]. Oxidative stress is a consequence of overproducing or inadequate removal of ROS in the cells, causing impairment of the oxidant-antioxidant balance in the body and may lead to non-specific damages of different biomolecules such as proteins, lipids, and nucleic acids. In addition, combining L-dopa therapy with antioxidants (from natural or synthetic origin), may reduce the oxidative processes, decrease side-effects and provide symptomatic relief [<xref rid="bib0045" ref-type="bibr">9</xref>].</p><p id="par0035">The vitamin C possesses the strong antioxidant properties, and interacts with H<sub>2</sub>O<sub>2</sub>, hydroxyl radical (<sup>&#x02022;</sup>OH) and <sup>&#x02022;</sup>O<sub>2</sub><sup>&#x02212;</sup>, and turning them into non-radical products, providing cells with a free radical &#x0201c;neutralizer&#x0201d; [<xref rid="bib0050" ref-type="bibr">10</xref>,<xref rid="bib0055" ref-type="bibr">11</xref>]. In addition, the Vitamin C exhibit pro-oxidant properties in the presence of free transition metals, because it reduces ferrions to ferro-ions in a Fenton-like reaction and in the H<sub>2</sub>O<sub>2</sub> presence stimulate the hydroxyl radicals formation [<xref rid="bib0060" ref-type="bibr">12</xref>]. Whether the ultimate effect will be a pro-oxidant or an antioxidant depends on the ratio of the ascorbic acid concentration to the available ferrions [<xref rid="bib0065" ref-type="bibr">13</xref>]. At sufficiently high concentrations, ascorbic acid reduces and destroys the formed radicals [<xref rid="bib0070" ref-type="bibr">14</xref>,<xref rid="bib0075" ref-type="bibr">15</xref>]. Plasma antioxidants traceability under oxidative stress indicates that the ascorbic acid level has been lowered at the earliest, and after depletion, lipid peroxidation has developed, even if the plasma Tocopherol is in normal concentrations [<xref rid="bib0080" ref-type="bibr">16</xref>].</p><p id="par0040">Natural antioxidants are isolated from different parts of plants, like flowers, seeds, leaves, roots, bark and their phenolic extracts can slow the lipid oxidation [<xref rid="bib0085" ref-type="bibr">17</xref>]. Essential Rose oil (Rosa damascena Mill. f. Trigintipetala Dieck) is an integral part of traditional homeopathic medicine, because its antioxidant properties [<xref rid="bib0090" ref-type="bibr">18</xref>], neuropharmacological effects [<xref rid="bib0095" ref-type="bibr">19</xref>], and relaxant effects [<xref rid="bib0100" ref-type="bibr">20</xref>]. Bulgarian rose oil is a mixture of over 300 components belonging to the terpene and non-terpene hydrocarbons, glycosides, flavonoids [<xref rid="bib0105" ref-type="bibr">21</xref>], citronellol (20&#x02013;34%), Geraniol (15&#x02013;22%), Farnesol (2.35%), Neroll (5&#x02013;12%), linalool and esters [<xref rid="bib0105" ref-type="bibr">21</xref>]. In addition, some components of rose oil as anthocyanins, flavonoids, terpenes, glycosides, kaempferol and quercetin, have antioxidant activity [<xref rid="bib0110" ref-type="bibr">22</xref>,<xref rid="bib0115" ref-type="bibr">23</xref>]. Moreover, Ulusoy et al. [<xref rid="bib0115" ref-type="bibr">23</xref>]. has evaluated the chemical compositions of rose oil isolated from Rose Damascena Mill. by GC&#x02013;MS and found the main constituents were citronellol and geraniol (&#x0003e;55%). Nevertheless, phenylpropanoid such as eugenol is also an important component in rose essential oil [<xref rid="bib0120" ref-type="bibr">24</xref>]. Several studies indicate that the rose oil has a wide range of biochemical activities, such as scavenging free radicals, antimutagenic and antidepressant effects which may partly be due to the phenolics abundance [<xref rid="bib0080" ref-type="bibr">16</xref>,<xref rid="bib0125" ref-type="bibr">25</xref>]. Oil polar phenolics have a scavenging activity against superoxide anion (<sup>&#x02022;</sup>O<sub>2</sub>&#x0203e;) and hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>), also a capability to prevent the ROS generation. In vitro inhibitory the effect on eicosanoids production and on platelet aggregation have also indicated their capacity to scavenge nitrogen reactive species (RNS) such as peroxynitrite (NOO&#x0203e;) suggests a protective effect against nitration of tyrosine and DNA and protein damage [<xref rid="bib0130" ref-type="bibr">26</xref>].</p><p id="par0045">The aim of the present study was to investigate whether the pretreatment with antioxidants would decrease oxidative stress induced by the L-dopa. To achieve the ultimate goal of this research, we investigated the levels of lipid peroxidation measured as MDA, protein carbonyl content (PCC), and advanced glycation end products (AGEs) in blood plasma of experimental model of healthy mice.</p></sec><sec id="sec0010"><label>2</label><title>Materials and methods</title><sec id="sec0015"><label>2.1</label><title>Chemicals</title><p id="par0050">2-Thiobarbituric acid (TBA), L-3,4 dihydroxyphenyl alanine (L-dopa), L-Ascorbic acid were purchased from Sigma-Aldrich Chemie GmbH (Germany). All other chemicals that were used in the study were analytical grade. Deionized and distilled water were used for all experiments. Essential Rose oil was provided from the Institute for Roses and Aromatic Plants, Kazanluk, Bulgaria.</p></sec><sec id="sec0020"><label>2.2</label><title>Animals</title><p id="par0055">In the experiment were used male non-inbred albino mice (25&#x02013;40&#x02009;g). The experimental animals were housed in polycarbonate cages in controlled conditions: 12&#x02009;h light/dark cycles, 18&#x02013;23&#x02009;&#x000b0;C and humidity 55%, with free access to tap water, provided by the Trakia University vivarium, Stara Zagora, Bulgaria. The animal procedures were in accordance with <italic>Directive 2010/63/EU</italic> on the protection of animals used for experimental and other scientific work, and approved by the <italic>Ethical Committee for Animals of BABH and Trakia University, Stara Zagora, Bulgaria (131/ 6000-0333/ 09.12.2015)</italic>.</p><p id="par0060">Mice were divided into four groups (12 animals in each group). The control group of mice was inoculated two i.p. injections with solvent, only. The second injection was administered 45&#x02009;min after the first. To study the L-dopa effect we used the acute model [<xref rid="bib0135" ref-type="bibr">27</xref>]. The mice from all tested groups (except controls) received either two i.p. injections of L-dopa (100&#x02009;mg/kg) followed by benserazide (10&#x02009;mg/kg). The second injection was administered 45&#x02009;min after the first. The groups undergoing combination therapy were pre-treated first for 1&#x02009;h with i.p. injections with Ascorbic acid (400&#x02009;mg/kg), Rose oil (400&#x02009;mg/kg) and after that received L-dopa and benserazide. All mice were sacrificed by light anesthesia (Nembutal 50&#x02009;mg/kg i.p.) after 30&#x02009;min. Fresh blood (1-2 cm<sup>3</sup>) was collected directly from the heart in cold EDTA-containers (5&#x02009;cm<sup>3</sup> Monovette, Germany), and centrifuged at 4000&#x02009;rpm, 10&#x02009;min, 4&#x02009;&#x000b0;C and plasma samples were carefully separated.</p></sec><sec id="sec0025"><label>2.3</label><title>Ex vivo spectrophotometry assay for evaluation the levels of MDA</title><p id="par0065">To evaluate the levels of lipid peroxidation was used Thiobarbituric acid reactive substances (TBARS) assay, which measures MDA reactive substances [<xref rid="bib0140" ref-type="bibr">28</xref>]. The spectrophotometric measurements were performed on a Thermo Scientific spectrophotometer.</p></sec><sec id="sec0030"><label>2.4</label><title>Enzyme-linked immunosorbent assay</title><p id="par0070">Preliminarily were determined the total protein amount in the test sample with the Total Protein Kit, Human. Each protein sample were diluted to 10&#x02009;&#x003bc;g/mL in 1X PBS, pH&#x02009;=&#x02009;7.4 prior to use in the assay. Protein carbonyl content was measured using an OxiSelect protein carbonyl ELISA kit (Cell Biolabs). Briefly, the BSA standard (reduced/oxidized) and the assayed samples (10&#x02009;&#x003bc;g/mL) were adsorbed on a 96-well plate for 2&#x02009;h at 37&#x02009;&#x000b0;C. Protein carbonyl found in samples and standard reacted with DNPH to form DNP hydrazone, treated with anti-DNP antibody and HRP conjugated secondary antibody. Protein carbon content in the samples was determined by a standard curve prepared from the absorbance obtained on the basis of the oxidized/reduced BSA standards and the protein carbonyl content in the samples were calculated in nmol/mg.</p><p id="par0075">The AGEs level was similarly assessed with an OxiSelect AGE competitive ELISA kit (Cell Biolabs). an AGE conjugate is coated on an ELISA plate. The unknown AGE protein samples or AGEBSA standards are then added to the AGE conjugate preabsorbed ELISA plate. After a brief incubation, an anti-AGE polyclonal antibody is added, followed by an HRP conjugated secondary antibody. The content of AGE protein adducts in unknown samples is determined by comparison with a predetermined AGE-BSA standard curve.</p></sec><sec id="sec0035"><label>2.5</label><title>Statistical analysis</title><p id="par0080">Statistical analysis was performed with Statistica 7, StaSoft, Inc. and the results were expressed as means&#x02009;&#x000b1;&#x02009;S.E. All data were expressed as mean&#x02009;&#x000b1;&#x02009;SE and obtained by one-way ANOVA. p&#x02009;&#x0003e;&#x02009;0.05 was considered statistically significant. To define which groups are different from each other were used LSD post hoc tests.</p></sec></sec><sec id="sec0040"><label>3</label><title>Results</title><p id="par0085">In the current manuscript was investigated the possibilities of reducing the oxidative stress induced by L-dopa by combining with liposoluble Rose oil [<xref rid="bib0145" ref-type="bibr">29</xref>]. The results were compared with animals treated with L-dopa alone and with a reference antioxidant &#x02013;vitamin C (ascorbic acid). Based on literature data [<xref rid="bib0150" ref-type="bibr">30</xref>], we selected the 400&#x02009;mg/kg dose as "protector" for essential oils and the referent antioxidants &#x02013;ascorbic acid.</p><sec id="sec0045"><label>3.1</label><title>MDA levels in blood plasma</title><p id="par0090"><xref rid="fig0005" ref-type="fig">Fig. 1</xref> shows the plasma MDA level in healthy untreated mice and mice treated with L-dopa and combinations of L-dopa with Rose oil.<fig id="fig0005"><label>Fig. 1</label><caption><p>The MDA level in mice treated with L-dopa alone and in combination of L-dopa <bold>+</bold> SLENU/ Ascorbic acid/Rose oil, were statistically significant higher vs controls, p&#x02009;&#x0003c;&#x02009;0.00, t-test. To define which groups are different from each other have used LSD post hoc test. The results are presented as mean&#x02009;&#x000b1;&#x02009;S.E. p&#x02009;&#x0003c;&#x02009;0.01; (*) vs to controls; (**) vs L-dopa.</p></caption><alt-text id="at0070">Fig. 1</alt-text><graphic xlink:href="gr1"/></fig></p><p id="par0095">The lipid peroxidation products measured as MDA level from mice treated with L-dopa alone was statistically higher compared to controls (mean 3.75&#x02009;&#x000b1;&#x02009;0.12&#x02009;&#x003bc;mol/mL, vs mean 1.77&#x02009;&#x000b1;&#x02009;0.03&#x02009;&#x003bc;mol/mL, p&#x02009;&#x0003c;&#x02009;0.00, t &#x02013;test). The MDA level in the combination L-dopa&#x02009;+&#x02009;Ascorbic acid is statistically significantly higher than in controls (mean 2.08&#x02009;&#x000b1;&#x02009;0.04&#x02009;&#x003bc;mol/mL vs mean 1.77&#x02009;&#x000b1;&#x02009;0.03&#x02009;&#x003bc;mol/mL, p&#x02009;&#x0003c;&#x02009;0.00, t &#x02013;test) and statistically significantly lower than in mice treated with L-dopa alone (mean 2.08&#x02009;&#x000b1;&#x02009;0.04&#x02009;&#x003bc;mol/mL vs mean3.75&#x02009;&#x000b1;&#x02009;0.12&#x02009;&#x003bc;mol/mL, &#x00440; &#x0003c;0.00, t&#x02013;test). MDA level in combination L-dopa&#x02009;+&#x02009;Rose oil is statistically significantly higher than controls (mean 2.16&#x02009;&#x000b1;&#x02009;0.05&#x02009;&#x003bc;mol/mL vs mean 1.77&#x02009;&#x000b1;&#x02009;0.03&#x02009;&#x003bc;mol/mL, p&#x02009;&#x0003c;&#x02009;0.00, t-test), and statistically lower than samples treated with L-dopa alone (mean 2.16&#x02009;&#x000b1;&#x02009;0.05&#x02009;&#x003bc;mol/mL vs mean 23.75&#x02009;&#x000b1;&#x02009;0.12&#x02009;&#x003bc;mol/mL, p&#x02009;&#x0003c;&#x02009;0.00, t-test).</p></sec><sec id="sec0050"><label>3.2</label><title>Protein carbonyl content (PCC) determination in blood plasma</title><p id="par0100"><xref rid="fig0010" ref-type="fig">Fig. 2</xref> shows the PCC in blood plasma from mice treated with L-dopa alone and in combination with antioxidants. Compared to controls the PCC in L-dopa group is statistically significant higher then controls (mean 5.23&#x02009;&#x000b1;&#x02009;0.01&#x02009;nmol/mg vs mean 1.55&#x02009;&#x000b1;&#x02009;0.04&#x02009;nmol/mg, p&#x02009;&#x0003c;&#x02009;0.00, t&#x02013;test), and all group pretreated with combination L-dopa&#x02009;+&#x02009;antioxidants. Statistically significant increase in PCC is observed in group treated with L-dopa&#x02009;+&#x02009;Ascorbic acid versus controls (mean 3.18&#x02009;&#x000b1;&#x02009;0.09&#x02009;nmol/mg vs mean 1.55&#x02009;&#x000b1;&#x02009;0.04&#x02009;nmol /mg, p&#x02009;&#x0003c;&#x02009;0.00, t-test), but compared with group treated with L-dopa alone, the PCC level was statistically significant lower (mean 3.18&#x02009;&#x000b1;&#x02009;0.09&#x02009;nmol/mg vs. 5.23&#x02009;&#x000b1;&#x02009;0.01&#x02009;nmol/mg, p&#x02009;&#x0003c;&#x02009;0.00, t-test). The L-dopa&#x02009;+&#x02009;Rose oil combination compared to controls was statistically significantly higher (mean 3.07&#x02009;&#x000b1;&#x02009;0.02&#x02009;nmol/mg vs. mean 1.55&#x02009;&#x000b1;&#x02009;0.04&#x02009;nmol/mg, p&#x02009;&#x0003c;&#x02009;0.00, t-test), and statistically significantly lower in samples treated with L-dopa alone (mean 3.07&#x02009;&#x000b1;&#x02009;0.02&#x02009;nmol/mg vs. mean 5.23&#x02009;&#x000b1;&#x02009;0.35&#x02009;nmol/mg, p&#x02009;&#x0003c;&#x02009;0.00, t-test).<fig id="fig0010"><label>Fig. 2</label><caption><p>The protein carbonyl content (PCC) in mice treated with L-dopa alone and in combination of L-dopa&#x02009;+&#x02009;SLENU/ Ascorbic acid/ Rose oil were statistically significant higher than controls, p&#x02009;&#x0003c;&#x02009;0.00, t-test. To define which groups are different from each other have used LSD post hoc test. The results are presented as mean&#x02009;&#x000b1;&#x02009;S.E. p&#x02009;&#x0003c;&#x02009;0.01; (*) vs to controls; (**) vs L-dopa.</p></caption><alt-text id="at0075">Fig. 2</alt-text><graphic xlink:href="gr2"/></fig></p></sec><sec id="sec0055"><label>3.3</label><title>Advanced glycation end products (ages) blood plasma</title><p id="par0105">The AGEs (<xref rid="fig0015" ref-type="fig">Fig. 3</xref>) in blood plasma in group treated with L-dopa alone was statistically significantly higher compared to control group (982&#x02009;&#x000b1;&#x02009;14.69&#x02009;&#x003bc;g/ml vs 432&#x02009;&#x000b1;&#x02009;19.05&#x02009;&#x003bc;g/ml, p&#x02009;&#x0003c;&#x02009;0.00, t-test). Statistically significantly increase was observed in pretreated with antioxidants groups compared to controls: Ascorbic acid&#x02009;+&#x02009;L-dopa (686&#x02009;&#x000b1;&#x02009;21.6&#x02009;&#x003bc;g/ml, vs 432&#x02009;&#x000b1;&#x02009;19.05&#x02009;&#x003bc;g/ml, p&#x02009;&#x0003c;&#x02009;0.00, t-test), and Rose oil&#x02009;+&#x02009;L-dopa (489&#x02009;&#x000b1;&#x02009;13.1&#x02009;&#x003bc;g/ml, vs 432&#x02009;&#x000b1;&#x02009;19.05&#x02009;&#x003bc;g/ml, p&#x02009;&#x0003c;&#x02009;0.000, t-test). Both groups pretreated with antioxidants show statistically significant decrease compared to group treated with L-dopa alone (p&#x02009;&#x0003c;&#x02009;0.00).<fig id="fig0015"><label>Fig. 3</label><caption><p>Advanced glycation end products (AGEs) in blood plasma in mice treated with L-dopa alone and in combination of L-dopa&#x02009;+&#x02009;SLENU/Ascorbic acid/Rose oil were statistically significant higher than controls, p&#x02009;&#x0003c;&#x02009;0.00, t-test. To define which groups are different from each other have used LSD post hoc test. The results are presented as mean&#x02009;&#x000b1;&#x02009;S.E. p&#x02009;&#x0003c;&#x02009;0.01; (*) vs to controls; (**) vs L-dopa.</p></caption><alt-text id="at0080">Fig. 3</alt-text><graphic xlink:href="gr3"/></fig></p></sec><sec id="sec0060"><label>3.4</label><title>Correlations between parameters</title><p id="par0110">All parameters show positive correlation MDA vs AGEs show r&#x02009;=&#x02009;0.91, p&#x02009;=&#x02009;0.00; MDA vs PCC r&#x02009;=&#x02009;0.92, p&#x02009;=&#x02009;0.00; PCC vs AGEs show r&#x02009;=&#x02009;0.93, p&#x02009;=&#x02009;0.00.</p></sec></sec><sec id="sec0065"><label>4</label><title>Discussion</title><p id="par0115">L-dopa therapy is the most efficient method of Parkinson Disease treatment [<xref rid="bib0155" ref-type="bibr">31</xref>]. Although L-dopa has a relatively short half-life and is rapidly metabolized in plasma, the result of treatment is only symptomatic relief, and moreover, there is development of dyskinesia and ultimately worsening of the disease. In the current research, to evaluate whether OS is involved in L-dopa -induced toxicity was studied the influence of acute treatment with L-dopa on the OS biomarkers MDA, PCC and AGEs in experimental model of healthy mice. The protective effects of two different antioxidants an essential oil isolated from Rosa damascena <italic>Mill</italic>., and vitamin C was also investigated.</p><p id="par0120">The demand for natural antioxidants, especially with plant origin, has increased in recent years [<xref rid="bib0160" ref-type="bibr">32</xref>]. The effectiveness of antioxidants is probably limited by their bioavailability and the fact that they would have to be present in high concentrations to be able to compete with endogenous targets. Current result provides evidence that MDA level in plasma of acute model of mice treated with L-dopa alone was significantly higher than controls (<xref rid="fig0005" ref-type="fig">Fig. 1</xref>), meaning that L-dopa treatment induced OS in mice. Another indirect proof for OS involvement in drug-induced toxicity is the overcome by adding typical antioxidants [<xref rid="bib0155" ref-type="bibr">31</xref>,<xref rid="bib0165" ref-type="bibr">33</xref>]. Antioxidants are needed to prevent the formation and counteract the action of free radicals. In the present study MDA results obtained from a blood after treatment with the combinations L-dopa&#x02009;+&#x02009;Ascorbic acid and L-dopa&#x02009;+&#x02009;Rose oil shows levels commensurate with the controls and statistically decreased from the L-dopa group, only. This appears to confirm that the antioxidants can successfully limit peroxidation processes in lipids under the described experimental conditions. The intake of vitamin C and Rose oil is associated with a reduced risk of degenerative or chronic disease, possibly through antioxidant mechanisms [<xref rid="bib0080" ref-type="bibr">16</xref>]. Lipid peroxidation induced by OS and oxidants, generates a variety of lipid peroxidation products, including reactive proteins and more stable products as ketones, alkanes and malondialdehydes. These products react on cellular and tissular proteins and form adducts, which induced protein dysfunction and alter cellular response, and increase with aging together with antioxidant defense. MDA is formed during lipid peroxidation and binds to nucleophiles, is one of the most common aldehydes. In addition, MDA reacts with Lys residues, creating Schiff bases and plays an important role in the modulation of low density lipoproteins. The protein residues formed during oxidation of polyunsaturated fatty acid, leads to formation of stable Michael adducts with hemiacetal structure [<xref rid="bib0170" ref-type="bibr">34</xref>]. This reaction involve in fatty acid interaction with proteins, and their modification. As it seen in our model the improved antioxidant status helps to minimize oxidative damage, and thus can delay or prevent pathological changes. This suggests the potential benefits of antioxidant dietary strategies for reducing the amount of free radicals and their complications [<xref rid="bib0175" ref-type="bibr">35</xref>,<xref rid="bib0180" ref-type="bibr">36</xref>].</p><p id="par0125">The presented results show that the blood after treatment with L-dopa, compared with the controls, has a significant increase in the proteins (PCC, p&#x02009;&#x0003c;&#x02009;0.00). PCC assays involve interaction between the carbonyl group and 2, 4-dinitrophenylhydrazine (DNPH), which leads to formation of a stable dinitrophenyl (DNP) hydrazone product. The last is detected by enzyme -linked Immunosorbent assay (ELISA). DNPH method is useful to quantify carbonyl content in the mixture of proteins, such as plasma, tissue homogenates, cellular extracts, or in isolated proteins. Current results show a significant increase in the PCC level in the L-dopa treated group, compared with the control, which again clearly emphasizes that the oxidative stress caused by drug therapy is induced in the mice plasma. In addition, the groups treated with antioxidants show statistically significant decrease compared to L-dopa treated group (p&#x02009;&#x0003c;&#x02009;0.00, <xref rid="fig0010" ref-type="fig">Fig. 2</xref>). These results may be related to the presence of oxidative stress after treatment with L-dopa and show that antioxidants can slowly migrate proteins under oxidative conditions and protect them from oxidation [<xref rid="bib0185" ref-type="bibr">37</xref>].</p><p id="par0130">Advanced glycation end products (AGEs) are a heterogeneous, complex group of compounds that are formed mainly via the Maillard reaction. This reaction become as the reducing sugar reacts in a non-enzymatic way with amino acids in proteins, lipids or DNA. Protein carbonyl formation is an important marker for protein oxidation that results from free radical attack on amino acid side chains [<xref rid="bib0190" ref-type="bibr">38</xref>,<xref rid="bib0195" ref-type="bibr">39</xref>]. The PCC increases in stress and accumulated carbonyls cause protein damage and dysfunction. Augmented accumulation of AGEs may indicate an accelerated process of aging-related deterioration that likely accompanies neurodegeneration. However, AGEs mainly accumulate on long-lived proteins, and analysis of AGEs in blood may therefore not necessarily reflect their tissue levels, yet circulating AGEs keep their biomarker potential [<xref rid="bib0195" ref-type="bibr">39</xref>]. <italic>In vivo</italic> study the Maillard reaction products have received increasing attention due to AGEs association with certain chronic diseases, such as diabetes mellitus, Parkinson&#x02019;s disease and Alzheimer&#x02019;s disease, as well as during the aging process [<xref rid="bib0200" ref-type="bibr">40</xref>].</p><p id="par0135">Carbonyl stress induced progressively protein dysfunctions and harmed all tissues, with pathological consequences such as inflammation and apoptosis contributing to the diseases progress [<xref rid="bib0175" ref-type="bibr">35</xref>]. This proteins inhibiting could stop pathological consequences of carbonyl stress. Moreover, carbonyl stress is the accumulation of reactive di-carbonyls, whether due to an increase in substrate content or a decrease in detoxification. Such intermediate products can continue to form AGEs or, during accumulation, as in carbonyl stress, can only cause damage [<xref rid="bib0030" ref-type="bibr">6</xref>]. Reactive carbonyl compound (RCC) is formed endogenously during lipid peroxidation and the glycation of carbohydrates are precursors of advanced glycation products (AGEs), which form cross-links on tissular proteins (carbonyl stress) and accumulate during aging in chronic disease [<xref rid="bib0175" ref-type="bibr">35</xref>]. Various research groups investigated <italic>in vitro</italic> the antioxidant and free radical scavenging activities of ethanol and acetone extracts of fresh Rosa damascene flower petals. It was established a good expression of DPPH&#x00387; and ABTS<sup>+</sup> radical scavenging activity and compared with standard ascorbic acid [<xref rid="bib0170" ref-type="bibr">34</xref>]. Another research team studied methanol extracts obtained from various plants, including Rosa Damascena extract, containing significant amounts of polyphenols, and reported excellent antioxidant activity for this extract, as evidenced by the scavenging of DPPH&#x00387;, ABTS<sup>+</sup>, <sup>&#x02022;</sup>NO, <sup>&#x02022;</sup>OH, O<sub>2</sub> and ONOO&#x0203e; [<xref rid="bib0200" ref-type="bibr">40</xref>]. In the same study, Rosa damascena extract shows significant potential for preventing oxidative end-products and radical activity [<xref rid="bib0205" ref-type="bibr">41</xref>]. Phenols and flavonoids are the keys ingredients indicated in most essential plants (rose oil), which have been reported by a number of researchers to have antioxidant and free radical activity [<xref rid="bib0210" ref-type="bibr">42</xref>]. Natural polyphenols and terpenes contained in essential oil shows a protective effect on neurodegenerative diseases [<xref rid="bib0215" ref-type="bibr">43</xref>], which is due to their ability to cross the blood-brain barrier and directly to capture the chelated transition metal ions and ROS/RNS in pathological concentrations [<xref rid="bib0220" ref-type="bibr">44</xref>] and to exert antioxidant effects into brain [<xref rid="bib0225" ref-type="bibr">45</xref>,<xref rid="bib0230" ref-type="bibr">46</xref>]. Essential oils as antioxidants have been studied in detail to investigate their protective role for highly unsaturated lipids in animal tissues [<xref rid="bib0235" ref-type="bibr">47</xref>]. They shown their actions as hepatoprotective agents [<xref rid="bib0240" ref-type="bibr">48</xref>] and coincide with our results. Furthermore, oils possess antioxidant properties at extremely low dilution rates administered either by inhalation or by lipophilic fractions, interacting with the lipid parts of the cell membranes, thereby altering the calcium ion channels activity and in some dosas saturated the membranes [<xref rid="bib0245" ref-type="bibr">49</xref>].</p></sec><sec id="sec0070"><label>5</label><title>Conclusion</title><p id="par0140">This study shows that L-dopa induces oxidative toxicity proved by the increased levels of OS biomarkers MDA, PCC and AGEs tested in experimental model of healthy mice. The antioxidants &#x02013; Vitamin C and Rose oil, exhibit pronounced interfering and antioxidant properties against the acute oxidative toxicity of L-dopa. Furthermore, obviously the studied classic antioxidant, and essential oil can protect organisms from L-dopa oxidative toxicity induced and may play a key role in end products disarm. It must be emphasized, that Rosa damascena oil exhibited behavior very similar to the classic antioxidants &#x02013;vitamin C, making it potential candidates for extensive experimental research to their possible use as protectors against oxidative toxicity triggered by drug therapy of neurodegenerative diseases.</p></sec><sec sec-type="supplementary-material" id="sec0075"><title>Transparency document</title><p id="par0155"><supplementary-material content-type="local-data" id="upi0005"><caption><title>Transparency document</title></caption><media xlink:href="mmc1.zip"/></supplementary-material></p></sec></body><back><ref-list id="bibl0005"><title>References</title><ref id="bib0005"><label>1</label><element-citation publication-type="journal" id="sbref0005"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>B.</given-names></name><name><surname>Breydo</surname><given-names>L.</given-names></name><name><surname>Fink</surname><given-names>A.</given-names></name></person-group><article-title>Agrochemicals, &#x003b1;-synuclein, and Parkinson&#x02019;s disease</article-title><source>Molec Neurobiol.</source><volume>47</volume><year>2013</year><fpage>598</fpage><lpage>612</lpage><pub-id pub-id-type="pmid">22933040</pub-id></element-citation></ref><ref id="bib0010"><label>2</label><element-citation publication-type="journal" id="sbref0010"><person-group person-group-type="author"><name><surname>Petzinger</surname><given-names>G.</given-names></name><name><surname>Holschneider</surname><given-names>D.</given-names></name><name><surname>Fisher</surname><given-names>B.</given-names></name></person-group><article-title>The effects of exercise on dopamine neurotransmission in Parkinson&#x02019;s disease: targeting neuroplasticity to modulate basal ganglia circuitry</article-title><source>Brain Plast.</source><volume>1</volume><year>2015</year><fpage>29</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">26512345</pub-id></element-citation></ref><ref id="bib0015"><label>3</label><element-citation publication-type="journal" id="sbref0015"><person-group person-group-type="author"><name><surname>Fern&#x000e1;ndez</surname><given-names>B.</given-names></name><name><surname>Ferrer</surname><given-names>I.</given-names></name><name><surname>Gil</surname><given-names>F.</given-names></name></person-group><article-title>Biomonitorization of iron accumulation in the substantia nigra from Lewy body disease patients</article-title><source>Toxicol. Rep.</source><volume>4</volume><year>2017</year><fpage>188</fpage><lpage>193</lpage><pub-id pub-id-type="pmid">28529891</pub-id></element-citation></ref><ref id="bib0020"><label>4</label><element-citation publication-type="journal" id="sbref0020"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>S.</given-names></name><name><surname>Kennewell</surname><given-names>P.</given-names></name><name><surname>Russell</surname><given-names>A.</given-names></name></person-group><article-title>Wynne Stemistry: the control of stem cells in situ using chemistry</article-title><source>J. Med. Chem.</source><volume>58</volume><year>2015</year><fpage>2863</fpage><lpage>2894</lpage><pub-id pub-id-type="pmid">25590360</pub-id></element-citation></ref><ref id="bib0025"><label>5</label><element-citation publication-type="journal" id="sbref0025"><person-group person-group-type="author"><name><surname>Fahn</surname><given-names>S.</given-names></name></person-group><article-title>The medical treatment of Parkinson disease from James Parkinson to George Cotzias</article-title><source>Mov. Disord.</source><volume>30</volume><year>2015</year><fpage>4</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">25491387</pub-id></element-citation></ref><ref id="bib0030"><label>6</label><element-citation publication-type="journal" id="sbref0030"><person-group person-group-type="author"><name><surname>Fox</surname><given-names>S.</given-names></name><name><surname>Katzenschlager</surname><given-names>R.</given-names></name><name><surname>Lim</surname><given-names>S.</given-names></name></person-group><article-title>Movement Disorder Society Evidence Based Medicine Committee, International Parkinson and movement disorder society evidence based medicine review: Update on treatments for the motor symptoms of Parkinson&#x02019;s disease</article-title><source>Mov. Disord.</source><year>2018</year></element-citation></ref><ref id="bib0035"><label>7</label><element-citation publication-type="journal" id="sbref0035"><person-group person-group-type="author"><name><surname>Brott</surname><given-names>D.</given-names></name><name><surname>Andersson</surname><given-names>H.</given-names></name><name><surname>Stewart</surname><given-names>J.</given-names></name></person-group><article-title>A peripherally restricted P2Y12 receptor antagonist altered rat tumor incidences with no human relevance: mode of action consistent with dopamine agonism</article-title><source>Toxicol. Rep.</source><volume>1</volume><year>2014</year><fpage>1202</fpage><lpage>1212</lpage><pub-id pub-id-type="pmid">28962330</pub-id></element-citation></ref><ref id="bib0040"><label>8</label><element-citation publication-type="journal" id="sbref0040"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>R.</given-names></name><name><surname>Barden</surname><given-names>A.</given-names></name><name><surname>Mori</surname><given-names>T.</given-names></name></person-group><article-title>Advanced glycation end-products: a review</article-title><source>Diabetologia</source><volume>44</volume><year>2001</year><fpage>129</fpage><lpage>146</lpage><pub-id pub-id-type="pmid">11270668</pub-id></element-citation></ref><ref id="bib0045"><label>9</label><element-citation publication-type="journal" id="sbref0045"><person-group person-group-type="author"><name><surname>Roede</surname><given-names>J.</given-names></name><name><surname>Uppal</surname><given-names>K.</given-names></name><name><surname>Park</surname><given-names>Y.</given-names></name></person-group><article-title>Transcriptome&#x02013;metabolome wide association study (TMWAS) of maneb and paraquat neurotoxicity reveals network level interactions in toxicologic mechanism</article-title><source>Toxicol. Rep.</source><volume>1</volume><year>2014</year><fpage>435</fpage><lpage>444</lpage><pub-id pub-id-type="pmid">27722094</pub-id></element-citation></ref><ref id="bib0050"><label>10</label><element-citation publication-type="book" id="sbref0050"><person-group person-group-type="author"><name><surname>Valnet</surname><given-names>C.</given-names></name></person-group><chapter-title>Essential Oils and Aromatherapy</chapter-title><year>2015</year><publisher-name>Edizioni REI.</publisher-name></element-citation></ref><ref id="bib0055"><label>11</label><element-citation publication-type="book" id="sbref0055"><person-group person-group-type="author"><name><surname>Lei</surname><given-names>W.</given-names></name></person-group><chapter-title>Modulation of Inflammatory Responses by Sutherlandia frutescens</chapter-title><year>2015</year><publisher-name>University of Missouri-Columbia</publisher-name></element-citation></ref><ref id="bib0060"><label>12</label><element-citation publication-type="journal" id="sbref0060"><person-group person-group-type="author"><name><surname>Smirnoff</surname><given-names>N.</given-names></name></person-group><article-title>Ascorbic acid metabolism and functions: a comparison of plants and mammals</article-title><source>Free Rad. Biol. Med.</source><year>2018</year></element-citation></ref><ref id="bib0065"><label>13</label><element-citation publication-type="journal" id="sbref0065"><person-group person-group-type="author"><name><surname>Rahal</surname><given-names>A.</given-names></name><name><surname>Kumar</surname><given-names>V.</given-names></name><name><surname>Singh</surname><given-names>B.</given-names></name></person-group><article-title>Oxidative stress, prooxidants, and antioxidants: the interplay</article-title><source>Comput. Biomed. Res.</source><year>2014</year></element-citation></ref><ref id="bib0070"><label>14</label><element-citation publication-type="book" id="sbref0070"><person-group person-group-type="author"><name><surname>Halliwell</surname><given-names>J.</given-names></name></person-group><chapter-title>Gutteridge Free Radicals in Biology and Medicine</chapter-title><year>2015</year><publisher-name>Oxford University Press</publisher-name><publisher-loc>USA</publisher-loc></element-citation></ref><ref id="bib0075"><label>15</label><element-citation publication-type="journal" id="sbref0075"><person-group person-group-type="author"><name><surname>Jaiswal</surname><given-names>S.</given-names></name><name><surname>Gupta</surname><given-names>V.</given-names></name><name><surname>Ansari</surname><given-names>M.</given-names></name></person-group><article-title>Vitamin C acts as a hepatoprotectant in carbofuran treated rat liver slices in vitro</article-title><source>Toxicol. Rep.</source><volume>1</volume><issue>4</issue><year>2017</year><fpage>265</fpage><lpage>273</lpage></element-citation></ref><ref id="bib0080"><label>16</label><element-citation publication-type="journal" id="sbref0080"><person-group person-group-type="author"><name><surname>Nikolova</surname><given-names>G.</given-names></name><name><surname>Karamalakova</surname><given-names>Y.</given-names></name><name><surname>Kovacheva</surname><given-names>N.</given-names></name></person-group><article-title>Protective effect of two essential oils isolated from Rosa damascena Mill. And Lavandula angustifolia Mill, and two classic antioxidants against L-dopa oxidative toxicity induced in healthy mice</article-title><source>Regul. Toxicol. Pharmacol.</source><volume>81</volume><year>2016</year><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">27381452</pub-id></element-citation></ref><ref id="bib0085"><label>17</label><element-citation publication-type="journal" id="sbref0085"><person-group person-group-type="author"><name><surname>Sagdi&#x000e7;</surname><given-names>O.</given-names></name><name><surname>&#x000d6;zkan</surname><given-names>G.</given-names></name><name><surname>Baydar</surname><given-names>N.</given-names></name></person-group><article-title>Note: antioxidant and antibacterial activities of Rosa damascena flower extracts</article-title><source>Rev. Agaroquimica Y Tecnol. Aliment.</source><volume>10</volume><issue>4</issue><year>2004</year><fpage>277</fpage><lpage>281</lpage></element-citation></ref><ref id="bib0090"><label>18</label><element-citation publication-type="journal" id="sbref0090"><person-group person-group-type="author"><name><surname>Nyeem</surname><given-names>M.</given-names></name><name><surname>Alam</surname><given-names>M.</given-names></name><name><surname>Awal</surname><given-names>M.</given-names></name></person-group><article-title>CNS depressant effect of the crude ethanolic extract of the flowering tops of Rosa damascena</article-title><source>Iran. J. Pharm. Res.</source><volume>5</volume><year>2007</year><fpage>171</fpage><lpage>174</lpage></element-citation></ref><ref id="bib0095"><label>19</label><element-citation publication-type="journal" id="sbref0095"><person-group person-group-type="author"><name><surname>Boskabady</surname><given-names>M.</given-names></name><name><surname>Kiani</surname><given-names>S.</given-names></name><name><surname>Rakhshandah</surname><given-names>H.</given-names></name></person-group><article-title>Relaxant effects of Rosa damascena on guinea pig tracheal chains and its possible mechanism (s)</article-title><source>J. Ethnopharm.</source><volume>106</volume><year>2006</year><fpage>377</fpage><lpage>382</lpage></element-citation></ref><ref id="bib0100"><label>20</label><element-citation publication-type="journal" id="sbref0100"><person-group person-group-type="author"><name><surname>Rusanov</surname><given-names>K.</given-names></name><name><surname>Kovacheva</surname><given-names>N.</given-names></name><name><surname>Atanassov</surname><given-names>A.</given-names></name></person-group><article-title>Rosa damascena Mill., the oil-bearing Damask rose: genetic resources, diversity and perspectives for molecular breeding</article-title><source>Floricult. Ornamental Biotechnol.</source><volume>3</volume><year>2009</year><fpage>14</fpage><lpage>20</lpage></element-citation></ref><ref id="bib0105"><label>21</label><element-citation publication-type="book" id="sbref0105"><person-group person-group-type="author"><name><surname>Duke</surname><given-names>J.</given-names></name><name><surname>Cseke</surname><given-names>L.</given-names></name><name><surname>Warber</surname><given-names>S.</given-names></name></person-group><chapter-title>Natural Products From Plants</chapter-title><year>2016</year><publisher-name>CRC press</publisher-name></element-citation></ref><ref id="bib0110"><label>22</label><element-citation publication-type="journal" id="sbref0110"><person-group person-group-type="author"><name><surname>Slavov</surname><given-names>A.</given-names></name><name><surname>Vasileva</surname><given-names>I.</given-names></name><name><surname>Stefanov</surname><given-names>L.</given-names></name></person-group><article-title>Valorization of wastes from the rose oil industry</article-title><source>Rev. Environ. Sci. Biotechnol.</source><volume>16</volume><year>2017</year><fpage>309</fpage><lpage>325</lpage></element-citation></ref><ref id="bib0115"><label>23</label><element-citation publication-type="journal" id="sbref0115"><person-group person-group-type="author"><name><surname>Ulusoy</surname><given-names>S.</given-names></name><name><surname>Bosgelmez-Tmaz</surname><given-names>G.</given-names></name><name><surname>Secilmis-Canbay</surname><given-names>H.</given-names></name></person-group><article-title>Tocopherol, carotene, phenolic contents and antibacterial properties of rose essential oil, hydrosol and absolute</article-title><source>Curr. Microbiol.</source><volume>59</volume><year>2009</year><fpage>554</fpage><pub-id pub-id-type="pmid">19688375</pub-id></element-citation></ref><ref id="bib0120"><label>24</label><element-citation publication-type="journal" id="sbref0120"><person-group person-group-type="author"><name><surname>Mahboubi</surname><given-names>M.</given-names></name></person-group><article-title>Rosa damascena as holy ancient herb with novel applications</article-title><source>Afr. J. Tradit. Complement. Altern. Med.</source><volume>6</volume><year>2016</year><fpage>10</fpage><lpage>16</lpage></element-citation></ref><ref id="bib0125"><label>25</label><element-citation publication-type="journal" id="sbref0125"><person-group person-group-type="author"><name><surname>Hongratanaworakit</surname><given-names>T.</given-names></name></person-group><article-title>Relaxing effect of rose oil on humans</article-title><source>Nat. Prod. Commun.</source><volume>4</volume><year>2009</year><fpage>291</fpage><lpage>296</lpage><pub-id pub-id-type="pmid">19370942</pub-id></element-citation></ref><ref id="bib0130"><label>26</label><element-citation publication-type="journal" id="sbref0130"><person-group person-group-type="author"><name><surname>Dimitrios</surname><given-names>B.</given-names></name></person-group><article-title>Sources of natural phenolic antioxidants</article-title><source>Trends Food Sci. Technol.</source><volume>17</volume><year>2006</year><fpage>505</fpage><lpage>512</lpage></element-citation></ref><ref id="bib0135"><label>27</label><element-citation publication-type="journal" id="sbref0135"><person-group person-group-type="author"><name><surname>Bottiglieri</surname><given-names>T.</given-names></name><name><surname>Arning</surname><given-names>E.</given-names></name><name><surname>Wasek</surname><given-names>B.</given-names></name></person-group><article-title>Acute administration of L-DOPA induces changes in methylation metabolites, reduced protein phosphatase 2A methylation, and hyperphosphorylation of Tau protein in mouse brain</article-title><source>J. Neurosci.</source><volume>32</volume><year>2012</year><fpage>9173</fpage><lpage>9181</lpage><pub-id pub-id-type="pmid">22764226</pub-id></element-citation></ref><ref id="bib0140"><label>28</label><element-citation publication-type="journal" id="sbref0140"><person-group person-group-type="author"><name><surname>Plaser</surname><given-names>Z.</given-names></name><name><surname>Cushman</surname><given-names>L.</given-names></name><name><surname>Jonson</surname><given-names>B.</given-names></name></person-group><article-title>Estimation of product of lipid peroxidation (Malonyl Dialdehyde) in biochemical systems</article-title><source>Anal. Biochem.</source><volume>16</volume><year>1966</year><fpage>359</fpage><lpage>364</lpage><pub-id pub-id-type="pmid">6007581</pub-id></element-citation></ref><ref id="bib0145"><label>29</label><element-citation publication-type="journal" id="sbref0145"><person-group person-group-type="author"><name><surname>Umezu</surname><given-names>T.</given-names></name><name><surname>Nagano</surname><given-names>K.</given-names></name><name><surname>Ito</surname><given-names>H.</given-names></name></person-group><article-title>Anticonflict effects of lavender oil and identification of its active constituents</article-title><source>Pharmacol. Biochem. Behav.</source><volume>85</volume><year>2006</year><fpage>713</fpage><lpage>721</lpage><pub-id pub-id-type="pmid">17173962</pub-id></element-citation></ref><ref id="bib0150"><label>30</label><element-citation publication-type="journal" id="sbref0150"><person-group person-group-type="author"><name><surname>Melo</surname><given-names>A.</given-names></name><name><surname>Monteiro</surname><given-names>L.</given-names></name><name><surname>Lima</surname><given-names>R.</given-names></name></person-group><article-title>Oxidative stress in neurodegenerative diseases: mechanisms and therapeutic perspectives</article-title><source>Oxidative Med. Cell Longev</source><year>2011</year></element-citation></ref><ref id="bib0155"><label>31</label><element-citation publication-type="journal" id="sbref0155"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>J.</given-names></name><name><surname>Xiong</surname><given-names>Y.</given-names></name></person-group><article-title>Natural antioxidants as food and feed additives to promote health benefits and quality of meat products: a review</article-title><source>Meat Sci. Vet. Public Health</source><volume>120</volume><year>2016</year><fpage>107</fpage><lpage>117</lpage></element-citation></ref><ref id="bib0160"><label>32</label><element-citation publication-type="journal" id="sbref0160"><person-group person-group-type="author"><name><surname>Alam</surname><given-names>Z.</given-names></name><name><surname>Jenner</surname><given-names>A.</given-names></name><name><surname>Daniel</surname><given-names>S.</given-names></name></person-group><article-title>Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8&#x02010;hydroxyguanine levels in substantia nigra</article-title><source>J. Neurochem.</source><volume>69</volume><issue>3</issue><year>1997</year><fpage>1196</fpage><lpage>1203</lpage><pub-id pub-id-type="pmid">9282943</pub-id></element-citation></ref><ref id="bib0165"><label>33</label><element-citation publication-type="journal" id="sbref0165"><person-group person-group-type="author"><name><surname>Kuo</surname><given-names>Y.</given-names></name><name><surname>Nussbaum</surname><given-names>R.</given-names></name></person-group><article-title>Prolongation of chemically-induced methemoglobinemia in mice lacking &#x003b1;-synuclein: a novel pharmacologic and toxicologic phenotype</article-title><source>Toxicol. Rep.</source><volume>2</volume><year>2015</year><fpage>504</fpage><lpage>511</lpage><pub-id pub-id-type="pmid">25859428</pub-id></element-citation></ref><ref id="bib0170"><label>34</label><element-citation publication-type="journal" id="sbref0170"><person-group person-group-type="author"><name><surname>Negre</surname><given-names>A.</given-names></name><name><surname>Salvayre</surname><given-names>C.</given-names></name><name><surname>Coatrieux</surname><given-names>C.</given-names></name></person-group><article-title>Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors</article-title><source>Brit. J. Pharmacol</source><volume>153</volume><year>2008</year><fpage>6</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">17643134</pub-id></element-citation></ref><ref id="bib0175"><label>35</label><element-citation publication-type="journal" id="sbref0175"><person-group person-group-type="author"><name><surname>Uttara</surname><given-names>A.</given-names></name><name><surname>Singh</surname><given-names>P.</given-names></name><name><surname>Zamboni</surname><given-names>R.</given-names></name></person-group><article-title>Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options</article-title><source>Curr. Neuropharmacol.</source><volume>7</volume><year>2009</year><fpage>65</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">19721819</pub-id></element-citation></ref><ref id="bib0180"><label>36</label><element-citation publication-type="journal" id="sbref0180"><person-group person-group-type="author"><name><surname>Hondur</surname><given-names>G.</given-names></name><name><surname>G&#x000f6;kta&#x0015f;</surname><given-names>E.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name></person-group><article-title>Oxidative stress&#x02013;related molecular biomarker candidates for Glaucoma</article-title><source>Investig. Ophthalmol. Visual Sci.</source><volume>58</volume><issue>10</issue><year>2017</year><fpage>4078</fpage><lpage>4088</lpage><pub-id pub-id-type="pmid">28820925</pub-id></element-citation></ref><ref id="bib0185"><label>37</label><element-citation publication-type="journal" id="sbref0185"><person-group person-group-type="author"><name><surname>Oscar</surname><given-names>A.</given-names></name><name><surname>Cherninkova</surname><given-names>S.</given-names></name><name><surname>Haykin</surname><given-names>V.</given-names></name></person-group><article-title>Amblyopia screening in Bulgaria</article-title><source>J. Pediatr. Ophthalmol. Strabismus</source><volume>51</volume><issue>5</issue><year>2014</year><fpage>284</fpage><lpage>288</lpage><pub-id pub-id-type="pmid">24971584</pub-id></element-citation></ref><ref id="bib0190"><label>38</label><element-citation publication-type="journal" id="sbref0190"><person-group person-group-type="author"><name><surname>Tatke</surname><given-names>P.</given-names></name><name><surname>Patil</surname><given-names>P.</given-names></name><name><surname>Gabhe</surname><given-names>S.</given-names></name></person-group><article-title>In vitro antioxidant and free radical scavenging activity of extracts of Rosa damascena flower petals</article-title><source>AJPCT</source><volume>3</volume><year>2015</year><fpage>589</fpage><lpage>601</lpage></element-citation></ref><ref id="bib0195"><label>39</label><element-citation publication-type="journal" id="sbref0195"><person-group person-group-type="author"><name><surname>Kalim</surname><given-names>M.</given-names></name><name><surname>Bhattacharyya</surname><given-names>D.</given-names></name><name><surname>Banerjee</surname><given-names>A.</given-names></name></person-group><article-title>Oxidative DNA damage preventive activity and antioxidant potential of plants used in Unani system of medicine</article-title><source>BMC Compl. Altern. Med.</source><volume>10</volume><year>2010</year><fpage>77</fpage></element-citation></ref><ref id="bib0200"><label>40</label><element-citation publication-type="journal" id="sbref0200"><person-group person-group-type="author"><name><surname>Manjamalai</surname><given-names>A.</given-names></name><name><surname>Grace</surname><given-names>V.</given-names></name></person-group><article-title>Antioxidant activity of essential oils from Wedelia chinensis (Osbeck) in vitro and in vivo lung cancer bearing C57BL/6 mice</article-title><source>Asian Pac. J. Cancer Prev.</source><volume>13</volume><year>2012</year><fpage>3065</fpage><lpage>3071</lpage><pub-id pub-id-type="pmid">22994711</pub-id></element-citation></ref><ref id="bib0205"><label>41</label><element-citation publication-type="journal" id="sbref0205"><person-group person-group-type="author"><name><surname>Mihaylova</surname><given-names>B.</given-names></name><name><surname>Petkova</surname><given-names>I.</given-names></name><name><surname>Ch</surname><given-names>Rankova-Yotova</given-names></name></person-group><article-title>Plasma endothelin-1 and endothelin-A receptor concentrations in patients with primary open-angle glaucoma</article-title><source>Biotechnol. Biotechnol. Eq.</source><volume>31</volume><issue>4</issue><year>2017</year><fpage>782</fpage><lpage>787</lpage></element-citation></ref><ref id="bib0210"><label>42</label><element-citation publication-type="journal" id="sbref0210"><person-group person-group-type="author"><name><surname>Aquilano</surname><given-names>K.</given-names></name><name><surname>Baldelli</surname><given-names>S.</given-names></name><name><surname>Rotilio</surname><given-names>G.</given-names></name></person-group><article-title>Role of nitric oxide synthases in Parkinson&#x02019;s disease: a review on the antioxidant and anti-inflammatory activity of polyphenols</article-title><source>Neurochem. Res.</source><volume>33</volume><issue>12</issue><year>2008</year><fpage>2416</fpage><lpage>2426</lpage><pub-id pub-id-type="pmid">18415676</pub-id></element-citation></ref><ref id="bib0215"><label>43</label><element-citation publication-type="journal" id="sbref0215"><person-group person-group-type="author"><name><surname>Mokni</surname><given-names>M.</given-names></name><name><surname>Elkahoui</surname><given-names>S.</given-names></name><name><surname>Limam</surname><given-names>F.</given-names></name></person-group><article-title>Effect of resveratrol on antioxidant enzyme activities in the brain of healthy rat</article-title><source>Neurochem. Res.</source><volume>32</volume><year>2007</year><fpage>981</fpage><lpage>987</lpage><pub-id pub-id-type="pmid">17401679</pub-id></element-citation></ref><ref id="bib0220"><label>44</label><element-citation publication-type="journal" id="sbref0220"><person-group person-group-type="author"><name><surname>Komsiiska</surname><given-names>D.</given-names></name><name><surname>Nikolova</surname><given-names>G.</given-names></name><name><surname>Karamalakova</surname><given-names>Y.</given-names></name></person-group><article-title>Real time oxidative stress markers of patients with post-stroke depression: EPR study</article-title><source>Bulg. Chem. Commun.</source><volume>50</volume><issue>Sp Iss C</issue><year>2018</year><fpage>64</fpage><lpage>68</lpage></element-citation></ref><ref id="bib0225"><label>45</label><element-citation publication-type="journal" id="sbref0225"><person-group person-group-type="author"><name><surname>Komsiiska</surname><given-names>D.</given-names></name></person-group><article-title>Oxydative stress and post-stroke depression</article-title><source>Tr J. Sci.</source><volume>3</volume><year>2018</year><fpage>249</fpage><lpage>253</lpage></element-citation></ref><ref id="bib0230"><label>46</label><element-citation publication-type="journal" id="sbref0230"><person-group person-group-type="author"><name><surname>Dakov</surname><given-names>N.</given-names></name><name><surname>St</surname><given-names>Kostova</given-names></name><name><surname>Tanev</surname><given-names>Iv.</given-names></name></person-group><article-title>Selective laser trabeculoplasty in primary open angle glaucoma - efficiency and correlated parameters</article-title><source>Compt. rend Acad. Bulg. Sci.</source><volume>71</volume><issue>2</issue><year>2018</year><fpage>288</fpage><lpage>298</lpage></element-citation></ref><ref id="bib0235"><label>47</label><element-citation publication-type="journal" id="sbref0235"><person-group person-group-type="author"><name><surname>Li</surname><given-names>T.</given-names></name><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Zhao</surname><given-names>P.</given-names></name></person-group><article-title>Evaluation of essential oil or/and emulsifier in low energy density diets on growth performance, nutrient digestibility, blood cholesterol and meat quality in finishing pigs</article-title><source>Ital. J. Anim. Sci.</source><volume>16</volume><issue>4</issue><year>2017</year><fpage>624</fpage><lpage>630</lpage></element-citation></ref><ref id="bib0240"><label>48</label><element-citation publication-type="journal" id="sbref0240"><person-group person-group-type="author"><name><surname>Sharifi-Rad</surname><given-names>J.</given-names></name><name><surname>Sureda</surname><given-names>A.</given-names></name><name><surname>Tenore</surname><given-names>G.</given-names></name></person-group><article-title>Biological activities of essential oils: from plant chemoecology to traditional healing systems</article-title><source>Molecules</source><volume>22</volume><issue>1</issue><year>2017</year><fpage>70</fpage></element-citation></ref><ref id="bib0245"><label>49</label><element-citation publication-type="book" id="sbref0245"><person-group person-group-type="author"><name><surname>Stine</surname><given-names>K.</given-names></name><name><surname>Brown</surname><given-names>T.</given-names></name></person-group><chapter-title>Principles of Toxicology</chapter-title><edition>3rd edition</edition><year>2015</year><publisher-name>Published CRC Press</publisher-name></element-citation></ref></ref-list><ack id="ack0005"><title>Acknowledgment</title><p>This work was supported by the <funding-source id="gs0005">scientific project &#x02116; 1/2018 Trakia University, Stara Zagora, Bulgaria</funding-source>.</p></ack></back></article>